Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infectionsGOLDSTEIN, Ellie J. C; CITRON, Diane M; MERRIAM, C. Vreni et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 4, pp 1136-1140, issn 0066-4804Article

Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial dataGESSER, Richard M; MCCARROLL, Kathleen; TEPPLER, Hedy et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 5, pp 1253-1260, issn 0305-7453, 8 p.Article

In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strainsBETRIU, Carmen; SANCHEZ, Ana; PALAU, Maria Luisa et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 8, pp 2372-2374, issn 0066-4804Article

Pharmacokinetics of intramuscularly administered ertapenemMUSSON, Donald G; MAJUMDAR, Anup; DEUTSCH, Paul et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1732-1735, issn 0066-4804, 4 p.Article

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc testsFUCHS, P. C; BARRY, A. L; BROWN, S. D et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 43, Num 5, pp 703-706, issn 0305-7453Article

Comparative in vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infectionsGOLDSTEIN, E. J. C; CITRON, D. M; MERRIAM, C. V et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 9, pp 2389-2394, issn 0066-4804Article

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centersFUCHS, Peter C; BARRY, Arthur L; BROWN, Steven D et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 6, pp 1915-1918, issn 0066-4804Article